February 2, 2023
(Reuters) – Biotech company Targacept Inc said British drugmaker AstraZeneca would return rights to several pre-clinical compounds, sending the U.S. company’s shares down 10 percent in extended…
Your email address will not be published.
Save my name, email, and website in this browser for the next time I comment.